Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03123055
Title A Study of B-701 in Combination With Atezolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma (U22)
Acronym FIERCE-22
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors BioClin Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | TUR | SWE | POL | NLD | ITA | HUN | FRA | ESP | DNK | DEU | BEL

Facility Status City State Zip Country Details
Research Site Greenbrae California 94904 United States Details
Research Site Fort Wayne Indiana 46845 United States Details
Research Site Louisville Kentucky 40202 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Research Site Cleveland Ohio 44195 United States Details
Research Site Philadelphia Pennsylvania 19107 United States Details
Research Site Germantown Tennessee 38138 United States Details
Research Site Houston Texas 77030 United States Details
Research Site Brussel 1000 Belgium Details
Research Site Leuven 3000 Belgium Details
Research Team Yvoir 5530 Belgium Details
Research Team Copenhagen 2100 Denmark Details
Research Site Bordeaux 33076 France Details
Research Site Dijon 21000 France Details
Research Site Dresden 01307 Germany Details
Research Site Frankfurt 60488 Germany Details
Research Site Heidelberg 69120 Germany Details
Research Site Kassel 34125 Germany Details
Research Site Munich 81377 Germany Details
Research Site Münster 48149 Germany Details
Research Site Budapest 1122 Hungary Details
Research Site Milano 20133 Italy Details
Research Site Milano 20141 Italy Details
Research Site Gwangju 61469 Korea, Republic of Details
Research Site Seongnam-si 13620 Korea, Republic of Details
Research Site Seoul 03722 Korea, Republic of Details
Research Site Seoul 06351 Korea, Republic of Details
Research Site Chisinau 2025 Moldova, Republic of Details
Research Site Utrecht 3584 CX Netherlands Details
Research Site Katowice 40-514 Poland Details
Research Site Warsaw 02-567 Poland Details
Research Site Warsaw 02-781 Poland Details
Research Site Wieliszew 05-135 Poland Details
Research Site Wroclaw 53-413 Poland Details
Research Site Moscow 125284 Russian Federation Details
Research Site Saint Petersburg 197758 Russian Federation Details
Research Team Ufa 450000 Russian Federation Details
Research Site Belgrade 11000 Serbia Details
Research Site Belgrade 11070 Serbia Details
Research Site Kragujevac 34000 Serbia Details
Research Site Niš 18000 Serbia Details
Research Site Sremska Kamenica 21204 Serbia Details
Research Site Madrid CA 28050 Spain Details
Research Site Barcelona 08035 Spain Details
Research Site Barcelona 08036 Spain Details
Research Site Madrid 28034 Spain Details
Research Site Madrid 28041 Spain Details
Research Site Uppsala 75185 Sweden Details
Research Site Ankara 06100 Turkey Details
Research Site Antalya 07059 Turkey Details
Research Site Dnipropetrovs'k 49102 Ukraine Details
Research Site Kiew 03022 Ukraine Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field